SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 153.57 |
| Enterprise Value ($M) | 88.85 |
| Book Value ($M) | 138.99 |
| Book Value / Share | 4.32 |
| Price / Book | 1.10 |
| NCAV ($M) | 138.89 |
| NCAV / Share | 4.31 |
| Price / NCAV | 1.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 20.34 |
| Current Ratio | 20.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 146.07 |
| Assets | 146.17 |
| Liabilities | 7.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -54.45 |
| Net Income | -45.57 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -42.44 |
| Cash from Investing | -61.68 |
| Cash from Financing | 104.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | AP11 Ltd | 5.40 | ||
| 13G/A | Point72 Asset Management, L.P. | 5.70 | -28.89 | |
| 13G/A | New Enterprise Associates 13 Lp | 0.00 | -100.00 | |
| 13G/A | Blue Owl Capital Holdings LP | 4.32 | -20.91 | |
| 13G/A | Baker Bros. Advisors Lp | 4.99 | 5.63 | |
| 13G/A | Hillhouse Capital Management, Ltd. | 2.40 | -50.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,792,295 | 5,911,340 | 30.32 | |
| 3,617,241 | 10,482,270 | 34.51 | |
| 47,903 | 363,847 | 13.17 | |
| 30,446 | 240,890 | 12.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RYTM – Rhythm Pharmaceuticals, Inc. | SAGE – Sage Therapeutics, Inc. |
| SCYX – SCYNEXIS, Inc. | SIGA – SIGA Technologies, Inc. |
| SKYE – Skye Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io